Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia : Current Opinion in Oncology

Secondary Logo

Journal Logo

HEMATOLOGIC MALIGNANCIES: Edited by Miguel A. Sanz and María-Victoria Mateos

Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia

Perutelli, Francescaa,b; Montalbano, Maria Chiaraa,b; Boccellato, Eliaa,b; Coscia, Martaa,b; Vitale, Candidaa,b

Author Information
Current Opinion in Oncology 34(6):p 757-767, November 2022. | DOI: 10.1097/CCO.0000000000000897

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid